Halozyme Therapeutics Inc (NASDAQ:HALO)

15.89
Delayed Data
As of Apr 20
 +0.59 / +3.86%
Today’s Change
6.88
Today|||52-Week Range
16.55
+64.66%
Year-to-Date

Today’s Trading

Previous close15.30
Today’s open15.54
Day’s range-- - --
Volume1,100,216
Average volume (3 months)1,466,659
Market cap$1.9B
Dividend yield--
Data as of 04/20/2015

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+10.25%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.47%
P/E ratioNM
Price/Sales15.72
Price/Book46.52

Competitors

 Today’s
change
Today’s
% change
OPHTOphthotech Corp-0.28-0.55%
NVAXNovavax Inc+0.22+2.73%
FMIFoundation Medicine ...+0.34+0.69%
ESPREsperion Therapeutic...-0.35-0.35%
Data as of 04/20/2015

Financials

Next reporting dateMay 8, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$75.3M
Annual profit (last year)-$68.4M
Net profit margin-90.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers